Animab

Animab, founded in 2020 and headquartered in Belgium, is a pioneering startup focused on enhancing animal production through biotechnology. The company’s slogan, "Cutting-edge biotechnology for better animal performance", encapsulates its mission to improve animal health and performance by leveraging advanced biotechnological research.

Animab distinguishes itself by targeting the gut's emerging science, offering innovative solutions that combine interdisciplinary research across animal science and biotechnology. The goal is to boost animal health, ensure cost-efficiency, and promote sustainability in production processes. The team, comprising industry veterans skilled in vaccines, biotechnology, and international marketing, is well-equipped to handle the diverse challenges of the industry.

The company recently secured a €10.00 million Series B investment from a notable consortium of investors, including Seventure Partners, PMV, QBIC, V-Bio Ventures, Acura Capital, Agri Investment Fund, and Flanders Institute for Biotechnology. This robust financial backing positions Animab to scale operations and further refine its product offerings in the biotechnology sector.